Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nila J. Dharan"'
Autor:
Jong-Seok Lee, Qian Gao, Myungsun Lee, Susan E. Dorman, Sang Nae Cho, Yingda L. Xie, David Alland, Sandra L. Hall, Xin Liu, Lili Liang, Nila J. Dharan, Ray Y. Chen, Laura E. Via, Peng Xu, Xing Yuan, Laura E. Smith, Jerrold J. Ellner, Xianglin Ruan, Derek T. Armstrong, Xiaoying Mo, Hong Zhu, Soumitesh Chakravorty, Joon Sung Joh, Taeksun Song, Young Soo Cho, Clifton E. Barry
Publikováno v:
The New England journal of medicine. 377(11)
Fluoroquinolones and second-line injectable drugs are the backbone of treatment regimens for multidrug-resistant tuberculosis, and resistance to these drugs defines extensively drug-resistant tuberculosis. We assessed the accuracy of an automated, ca
Autor:
Moses Joloba, David Alland, Susan E. Dorman, Jerrold J. Ellner, Martin Jones, Rachel W. Kubiak, Nila J. Dharan, Willy Ssengooba, Derek T. Armstrong, Robert Blakemore, Danielle Amisano, Gerald Mboowa, Yukari C. Manabe
Publikováno v:
Journal of Clinical Microbiology. 53:1258-1263
The Xpert MTB/RIF (Xpert) assay permits rapid near-patient detection of Mycobacterium tuberculosis in sputum; however, the test sensitivity remains suboptimal in paucibacillary specimens that are negative for acid-fast bacilli using smear microscopy.
Autor:
Alexander Klimov, Larisa V. Gubareva, Tiffany G. Sheu, Nila J. Dharan, Varough M. Deyde, Alicia M. Fry, Margaret Okomo-Adhiambo, Teresa R. Wallis
Publikováno v:
Antiviral Research. 81:16-24
Pyrosequencing has been successfully used to monitor resistance in influenza A viruses to the first class of anti-influenza drugs, M2 blockers (adamantanes). In contrast to M2 blockers, resistance to neuraminidase (NA) inhibitors (NAIs) is subtype- a
Autor:
Robert Blakemore, Alexander Sloutsky, Minoo Ghajar, Marie-Claire Rowlinson, Richard Alexander, David Alland, Kimberlee A. Musser, Nila J. Dharan, Eloise Valli, Vincent E. Escuyer, Susanne Crowe, Pamela Johnson, Rafael Laniado-Laborin, Devinder Kaur, Pamela Nabeta
Publikováno v:
BMC Infectious Diseases. 16(1)
The Xpert® MTB/RIF (Xpert) assay is a rapid PCR-based assay for the detection of Mycobacterium tuberculosis complex DNA (MTBc) and mutations associated with rifampin resistance (RIF). An updated version introduced in 2011, the G4 Xpert, included mod